[go: up one dir, main page]

BR0014308A - Formulação de veìculo farmacêutica - Google Patents

Formulação de veìculo farmacêutica

Info

Publication number
BR0014308A
BR0014308A BR0014308-1A BR0014308A BR0014308A BR 0014308 A BR0014308 A BR 0014308A BR 0014308 A BR0014308 A BR 0014308A BR 0014308 A BR0014308 A BR 0014308A
Authority
BR
Brazil
Prior art keywords
pharmaceutical vehicle
pvp
polyvinylpyrrolidone
fatty acid
formulation
Prior art date
Application number
BR0014308-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Joseph Kyuwung Yoon
Richard William Saunders
Mahdi Bakir Fawzi
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of BR0014308A publication Critical patent/BR0014308A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0014308-1A 1999-09-27 2000-09-26 Formulação de veìculo farmacêutica BR0014308A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40616499A 1999-09-27 1999-09-27
PCT/US2000/026381 WO2001022942A1 (en) 1999-09-27 2000-09-26 Pharmaceutical carrier formulation

Publications (1)

Publication Number Publication Date
BR0014308A true BR0014308A (pt) 2002-05-21

Family

ID=23606801

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014308-1A BR0014308A (pt) 1999-09-27 2000-09-26 Formulação de veìculo farmacêutica

Country Status (18)

Country Link
EP (1) EP1216029A1 (es)
JP (1) JP2003510267A (es)
KR (1) KR20020064289A (es)
CN (1) CN1399542A (es)
AR (1) AR025867A1 (es)
AU (1) AU7716100A (es)
BR (1) BR0014308A (es)
CA (1) CA2388471A1 (es)
CZ (1) CZ20021082A3 (es)
EA (1) EA200200415A1 (es)
HK (1) HK1044485A1 (es)
HU (1) HUP0202652A3 (es)
IL (1) IL148543A0 (es)
MX (1) MXPA02003190A (es)
NO (1) NO20021476L (es)
PL (1) PL354331A1 (es)
WO (1) WO2001022942A1 (es)
ZA (1) ZA200203311B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
WO2004073692A1 (ja) * 2003-02-18 2004-09-02 Yamashita, Shinji 難水溶性薬物のハードカプセル剤
CN100342856C (zh) * 2003-04-10 2007-10-17 上海医药工业研究院 达那唑半固体骨架制剂的组合物
EP1959935A2 (en) * 2005-10-26 2008-08-27 Banner Pharmacaps Inc. Hydrophilic vehicle-based dual controlled release matrix system as capsule fill
EP1951208A2 (en) 2005-10-26 2008-08-06 Banner Pharmacaps Inc. Lipophilic vehicle-based dual controlled release matrix system as capsule fill
AU2007313718A1 (en) * 2006-10-31 2008-05-08 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
BR112020003233B1 (pt) * 2017-12-20 2023-11-07 Firmenich S.A. Composições para cuidado oral

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
WO1995022331A1 (en) * 1994-02-18 1995-08-24 Cephalon, Inc. Aqueous indolocarbazole solutions
CA2318128C (en) * 1998-01-20 2008-10-14 Applied Analytical Industries, Inc. Oral liquid compositions

Also Published As

Publication number Publication date
NO20021476D0 (no) 2002-03-25
WO2001022942A1 (en) 2001-04-05
MXPA02003190A (es) 2002-09-30
ZA200203311B (en) 2003-12-31
CA2388471A1 (en) 2001-04-05
CN1399542A (zh) 2003-02-26
HUP0202652A3 (en) 2004-06-28
IL148543A0 (en) 2002-09-12
PL354331A1 (en) 2004-01-12
EA200200415A1 (ru) 2002-10-31
HK1044485A1 (zh) 2002-10-25
JP2003510267A (ja) 2003-03-18
EP1216029A1 (en) 2002-06-26
AR025867A1 (es) 2002-12-18
AU7716100A (en) 2001-04-30
HUP0202652A2 (hu) 2004-05-28
NO20021476L (no) 2002-04-16
CZ20021082A3 (cs) 2002-06-12
KR20020064289A (ko) 2002-08-07

Similar Documents

Publication Publication Date Title
EP2246049A3 (en) Pharmaceutical composition and dosage forms for administration of hydrophobic drugs
WO1999015210A3 (en) Bioadhesive compositions and methods for topical administration of active agents
AUPP310798A0 (en) Vehicle system for a composition comprising a piperidinopyrimidine derivative
ES2318061T3 (es) Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias.
AU3900300A (en) Improved aqueous solubility pharmaceutical formulations
CA2446060A1 (en) Compositions and delivery systems for administration of a local anesthetic agent
EA200501001A1 (ru) Фармацевтический состав с нерастворимым активным агентом
FI3834841T3 (fi) Stabiloituja neste- ja lyofilisoituja ADAMTS13-formulaatioita
PT1035844E (pt) Utilizacao de poliois no combate a infeccoes por leveduras e preparacoes de poliol para a referida utilizacao
BR0014308A (pt) Formulação de veìculo farmacêutica
US8993546B2 (en) Parasiticidal composition
CZ288631B6 (cs) Léčivé přípravky s obsahem cyklosporinu
WO1999012545A2 (en) Medicaments containing acyclovir
CA2423574A1 (en) Stabilization of solid drug formulations
IT1255968B (it) Composizioni farmaceutiche contenenti acido ursodesossicolico
ES2356774T3 (es) Composición farmacéutica fotoestable que contiene brivudina para el tratamiento de la queratitis herpética.
CA2406179A1 (en) Use of defibrotide and at least one haematopoietic factor to mobilize haematopoietic progenitors
ITFI20110100A1 (it) Formulazioni per uso topico contenenti lattoferrina, loro preparazione ed uso.
AU2809697A (en) Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
WO2008002118A1 (es) Una formulación oftálmica en suspensión de etabonato de loteprednol y clorhidrato de ciprofloxacina
DE60017938D1 (de) Arzneizusammensetzungen und herstellungsverfahren von ergotalkaloidhaltigen arzneizusammensetzungen mit verzögerter wirkstoffabgabe und verbesserter bioverfügbarkeit
ES2986010T3 (es) Composiciones tópicas diseñadas para mantener y/o restaurar la integridad de la mucosa y la epidermis dañadas
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
AR023705A1 (es) COMPOSICIoN ToPICA QUE COMPRENDE EL GLUCOCORTICOIDE ANTIINFLAMATORIO HIDROCORTISONA Y UN AGENTE ANTIVIRAL ANALOGO DE NUCLEOSIDO ACICLOVIR Y EL USO DE LA MISMA
US20050255161A1 (en) Method for the long term stabilization of labile compounds at room temperature in pharmaceutical preparations containing water

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]